HIV and drug-resistant subtypes

BM Nastri, P Pagliano, C Zannella, V Folliero… - Microorganisms, 2023 - mdpi.com
Acquired Immunodeficiency Syndrome (AIDS) is a human viral infectious disease caused by
the positive-sense single-stranded (ss) RNA Human Immunodeficiency Virus …

Fluorine in anti-HIV drugs approved by FDA from 1981 to 2023

S Han, Y Lu - European Journal of Medicinal Chemistry, 2023 - Elsevier
Human immunodeficiency virus (HIV) is the etiological agent of acquired immunodeficiency
syndrome (AIDS). Nowadays, FDA has approved over thirty antiretroviral drugs grouped in …

Contemporary medicinal chemistry strategies for the discovery and development of novel HIV-1 non-nucleoside reverse transcriptase inhibitors

Z Wang, S Cherukupalli, M Xie, W Wang… - Journal of Medicinal …, 2022 - ACS Publications
Currently, HIV-1 non-nucleoside reverse transcriptase inhibitors (NNRTIs) are a major
component of the highly active anti-retroviral therapy (HAART) regimen. However, the …

Impact of combined antiretroviral therapy on metabolic syndrome components in adult people living with HIV: A literature review

M Sapuła, M Suchacz, A Załęski, A Wiercińska-Drapało - Viruses, 2022 - mdpi.com
The development of metabolic derangements as a result of HIV treatment has been an
important area of research since the introduction of zidovudine in the 1980's. Antiretroviral …

Real-life use of Doravirine in treatment-experienced people living with HIV: A multicenter Italian study

M Mazzitelli, M Degli Antoni, F Castelli, D Ripamonti… - Medicine, 2022 - journals.lww.com
Real-life use of Doravirine in treatment-experienced people... : Medicine Real-life use of
Doravirine in treatment-experienced people living with HIV: A multicenter Italian study : Medicine …

Doravirine Plus Integrase Strand Transfer Inhibitors as a 2-Drug Treatment–Switch Strategy in People Living with HIV: The Real-Life DORINI Multicentric Cohort Study

M Poliseno, M Mazzitelli, A Narducci… - JAIDS Journal of …, 2023 - journals.lww.com
Background: Few data are available about the efficacy, durability, and tolerability of
doravirine (DOR)+ integrase strand inhibitors (INI) as a switching strategy among …

Residual phenotypic susceptibility to doravirine in multidrug-resistant HIV-1 from subjects enrolled in the PRESTIGIO registry

F Saladini, F Giammarino, F Maggiolo, M Ferrara… - International Journal of …, 2023 - Elsevier
Objectives Doravirine shows a rather distinct resistance profile within the nonnucleoside
reverse transcriptase inhibitor (NNRTI) class. This study aimed to evaluate the phenotypic …

Impact of Combination Antiretroviral Treatment on Liver Metabolic Health in HIV-Infected Persons

M Biały, M Czarnecki, M Inglot - Viruses, 2023 - mdpi.com
In the last three decades, there has been a considerable improvement in human
immunodeficiency virus (HIV) therapy. Acquired immunodeficiency syndrome (AIDS) is no …

Syntheses, crystal structure, luminescent properties and Hirshfeld surface of a set of triazole-based salts

BQ Jin, YQ Song, YX Ma, Y Zhou, GM Tang… - Journal of Molecular …, 2023 - Elsevier
To further investigate and explore the new luminescent materials, three new salts with
triazole-based skeletons, namely,[HCNT]+ X−(X= BS (1), PS (2) and SS∙ H 2 O (3))[CNT= 4 …

Identification of “dual-site”-binding diarylpyrimidines targeting both NNIBP and the NNRTI adjacent site of the HIV-1 reverse transcriptase

D Feng, X Zuo, F Zhao, H Lin, J Dai, Y Sun… - European journal of …, 2023 - Elsevier
Here, we reported a novel series of “dual-site” binding diarylpyrimidine (DAPY) derivatives
targeting both the NNRTI adjacent site and NNRTIs binding pocket (NNIBP). The anti-HIV-1 …